Solid Biosciences (SLDB) Net Equity Issued and Repurchased (2017 - 2024)
Solid Biosciences (SLDB) reported Net Equity Issued and Repurchased of $6.9 million for Q4 2024, up 1486.21% on a YoY basis from $435000.0 in Q1 2024, and up 122.58% sequentially from $3.1 million in Q3 2024.
Solid Biosciences (SLDB) Net Equity Issued and Repurchased (2017 - 2024) Analysis & Trends
Solid Biosciences (SLDB) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $6.9 million in Q4 2024.
- For the quarter ending Q4 2024, Net Equity Issued and Repurchased rose 1486.21% year-over-year to $6.9 million; the trailing twelve-month figure through Dec 2024 stood at $18.5 million (up 522.06% YoY), and the FY2025 full-year result was $6.8 million, down 63.04% from the prior year.
- Net Equity Issued and Repurchased grew to $6.9 million in Q4 2024, from $3.1 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $134.9 million in Q1 2021 to a low of $435000.0 in Q4 2023.
- A 3-year average of $22.3 million and a median of $3.1 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 1486.21% in 2024, while the deepest fall reached 112.68% in 2024.
- Tracing SLDB's Net Equity Issued and Repurchased over 3 years: stood at $134.9 million in 2021, then slumped by 99.68% to $435000.0 in 2023, then soared by 1486.21% to $6.9 million in 2024.
- Business Quant data shows SLDB's Net Equity Issued and Repurchased at $6.9 million in Q4 2024, $3.1 million in Q3 2024, and $5.4 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 6.90 Mn |
| Dec 31, 2024 | 6.90 Mn |
| Sep 30, 2024 | 3.10 Mn |
| Sep 30, 2024 | 3.10 Mn |
| Jun 30, 2024 | 5.40 Mn |
| Jun 30, 2024 | 5.40 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 435,000.00 |
| Dec 31, 2023 | 435,000.00 |
| Jun 30, 2023 | 2.54 Mn |
| Jun 30, 2023 | 2.54 Mn |
| Mar 31, 2021 | 134.88 Mn |
| Mar 31, 2021 | 134.88 Mn |
| Jun 30, 2017 | -500,000.00 |
| Jun 30, 2017 | -500,000.00 |
| Mar 31, 2017 | 25.00 Mn |
| Mar 31, 2017 | 25.00 Mn |